Limited indirect effects of an infant pneumococcal vaccination program in an aging population
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Limited indirect effects of an infant pneumococcal vaccination program in an aging population
Authors
Keywords
Vaccination and immunization, Germany, Vaccines, Age groups, Elderly, Conjugate vaccines, Epidemiology, Infants
Journal
PLoS One
Volume 14, Issue 8, Pages e0220453
Publisher
Public Library of Science (PLoS)
Online
2019-08-02
DOI
10.1371/journal.pone.0220453
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60+
- (2018) Cornelia Betsch et al. BMC PUBLIC HEALTH
- The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Study
- (2018) Anna M M van Deursen et al. CLINICAL INFECTIOUS DISEASES
- Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution
- (2018) Patricia Izurieta et al. Expert Review of Vaccines
- The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: a systematic review and meta-analysis
- (2018) Evelyn Balsells et al. JOURNAL OF INFECTION
- Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England
- (2018) Jo Southern et al. PLoS One
- Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants
- (2018) David Greenberg et al. VACCINE
- Pneumococcal vaccination patterns among persons aged 65 years or older in the United States: A retrospective database analysis
- (2018) Xiaoqin Yang et al. VACCINE
- Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage
- (2017) John Ojal et al. VACCINE
- Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies
- (2017) Myint Tin Tin Htar et al. PLoS One
- Background paper to the updated pneumococcal vaccination recommendation for older adults in Germany
- (2016) G. Falkenhorst et al. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz
- Incremental Cost-Effectiveness of 13-valent Pneumococcal Conjugate Vaccine for Adults Age 50 Years and Older in the United States
- (2016) Charles Stoecker et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England
- (2016) Albert Jan van Hoek et al. PLoS One
- Effectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in Germany
- (2016) Mark van der Linden et al. PLoS One
- Capsular Polysaccharide (CPS) Release by Serotype 3 Pneumococcal Strains Reduces the Protective Effect of Anti-Type 3 CPS Antibodies
- (2015) Eun Hwa Choi et al. Clinical and Vaccine Immunology
- Impact of 10- and 13-valent pneumococcal conjugate vaccines on incidence of invasive pneumococcal disease in children aged under 16 years in Germany, 2009 to 2012
- (2015) S Weiss et al. Eurosurveillance
- Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance
- (2015) Matthew R Moore et al. LANCET INFECTIOUS DISEASES
- Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
- (2015) Marc J.M. Bonten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emerging, Non-PCV13 Serotypes 11A and 35B of Streptococcus pneumoniae Show High Potential for Biofilm Formation In Vitro
- (2015) Mirian Domenech et al. PLoS One
- Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction
- (2015) Rebecca A. Gladstone et al. VACCINE
- Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines
- (2015) Tamara Pilishvili et al. VACCINE
- Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
- (2015) Miwako Kobayashi et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany
- (2015) Mark van der Linden et al. PLoS One
- Age-Dependent Prevalence of Nasopharyngeal Carriage of Streptococcus pneumoniae before Conjugate Vaccine Introduction: A Prediction Model Based on a Meta-Analysis
- (2014) Olivier Le Polain de Waroux et al. PLoS One
- Low Prevalence of Pneumococcal Carriage and High Serotype and Genotype Diversity among Adults over 60 Years of Age Living in Portugal
- (2014) Sónia T. Almeida et al. PLoS One
- Comparative Immunogenicity and Efficacy of 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines in Reducing Nasopharyngeal Colonization: A Randomized Double-Blind Trial
- (2013) Ron Dagan et al. CLINICAL INFECTIOUS DISEASES
- Improving vaccine uptake: An overview
- (2013) Michelle Anne Falconer Human Vaccines & Immunotherapeutics
- Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites
- (2013) Daniel R. Feikin et al. PLOS MEDICINE
- Understanding the pneumococcus: transmission and evolution
- (2013) Eric S. Donkor Frontiers in Cellular and Infection Microbiology
- The fundamental link between pneumococcal carriage and disease
- (2012) Birgit Simell et al. Expert Review of Vaccines
- Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia
- (2012) Thomas Bewick et al. THORAX
- Four years of universal pneumococcal conjugate infant vaccination in Germany: Impact on incidence of invasive pneumococcal disease and serotype distribution in children
- (2012) Mark van der Linden et al. VACCINE
- Serotype 3 is a common serotype causing invasive pneumococcal disease in children less than 5 years old, as identified by real-time PCR
- (2011) L. Selva et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines
- (2011) Jan Poolman et al. Expert Review of Vaccines
- Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe
- (2011) David S Fedson et al. Expert Review of Vaccines
- Effect of Pneumococcal Conjugate Vaccination on Serotype-Specific Carriage and Invasive Disease in England: A Cross-Sectional Study
- (2011) Stefan Flasche et al. PLOS MEDICINE
- Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
- (2009) Tamara Pilishvili et al. JOURNAL OF INFECTIOUS DISEASES
- Pneumococcal Capsular Polysaccharide Structure Predicts Serotype Prevalence
- (2009) Daniel M. Weinberger et al. PLoS Pathogens
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now